يعرض 1 - 10 نتائج من 307 نتيجة بحث عن '"Alan S. Coates"', وقت الاستعلام: 2.14s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence

    المؤلفون: Fabio Conforti, Laura Pala, Eleonora Pagan, Giuseppe Viale, Vincenzo Bagnardi, Giulia Peruzzotti, Tommaso De Pas, Nadia Bianco, Rossella Graffeo, Elena Guerini Rocco, Andrea Vingiani, Richard D. Gelber, Alan S. Coates, Marco Colleoni, Aron Goldhirsch

    المصدر: Breast Cancer Research, Vol 21, Iss 1, Pp 1-11 (2019)

    مصطلحات موضوعية: Lobular carcinoma, Late distant recurrence risk, KiCST5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/1465-542XTest

    الوصول الحر: https://doaj.org/article/2afa7f973c6a4034a4efdbf7da29b151Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    When do patient reported quality of life indicators become prognostic in breast cancer?

    المؤلفون: Chee Khoon Lee, Malcolm Hudson, John Simes, Karin Ribi, Jürg Bernhard, Alan S. Coates

    المصدر: Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-9 (2018)

    مصطلحات موضوعية: Breast cancer, Quality of life, Patient reported outcomes, Linear analog self-assessment, Prognostic factors, Survival, Computer applications to medicine. Medical informatics, R858-859.7

    وصف الملف: electronic resource

    العلاقة: http://link.springer.com/article/10.1186/s12955-017-0834-2Test; https://doaj.org/toc/1477-7525Test

    الوصول الحر: https://doaj.org/article/e22a8a513aaa46e6ab2a372a67106c5dTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  3. 3
    Abstract GS2-05: Randomized comparison of adjuvant aromatase inhibitor exemestane (E) plus ovarian function suppression (OFS) vs tamoxifen (T) plus OFS in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): update of the combined TEXT and SOFT trials

    المؤلفون: Meredith M Regan, Barbara A Walley, Gini F Fleming, Prudence A Francis, Marco A Colleoni, István Láng, Henry L Gómez, Carlo A Tondini, Harold J Burstein, Matthew P Goetz, Eva M Ciruelos, Vered Stearns, Hervé R Bonnefoi, Silvana Martino, Charles E Geyer, Claudio Chini, Alessandro M Minisini, Simon Spazzapan, Thomas Ruhstaller, Eric P Winer, Barbara Ruepp, Sherene Loi, Alan S Coates, Aron Goldhirsch, Richard D Gelber, Olivia Pagani

    المصدر: Cancer Research. 82:GS2-05

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::917f9c9b5826058c995d277405a9c367Test
    https://doi.org/10.1158/1538-7445.sabcs21-gs2-05Test


    أضف إلى المفضلة
  4. 4
    Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

    المؤلفون: Olivia, Pagani, Barbara A, Walley, Gini F, Fleming, Marco, Colleoni, István, Láng, Henry L, Gomez, Carlo, Tondini, Harold J, Burstein, Matthew P, Goetz, Eva M, Ciruelos, Vered, Stearns, Hervé R, Bonnefoi, Silvana, Martino, Charles E, Geyer, Claudio, Chini, Fabio, Puglisi, Simon, Spazzapan, Thomas, Ruhstaller, Eric P, Winer, Barbara, Ruepp, Sherene, Loi, Alan S, Coates, Richard D, Gelber, Aron, Goldhirsch, Meredith M, Regan, Prudence A, Francis

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb081c4bd1ec56269065c4f686c173aTest
    https://hdl.handle.net/11390/1243971Test


    أضف إلى المفضلة
  5. 5
    Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

    المؤلفون: Prudence A, Francis, Gini F, Fleming, István, Láng, Eva M, Ciruelos, Hervé R, Bonnefoi, Meritxell, Bellet, Antonio, Bernardo, Miguel A, Climent, Silvana, Martino, Begoña, Bermejo, Harold J, Burstein, Nancy E, Davidson, Charles E, Geyer, Barbara A, Walley, James N, Ingle, Robert E, Coleman, Bettina, Müller, Fanny, Le Du, Sibylle, Loibl, Eric P, Winer, Barbara, Ruepp, Sherene, Loi, Marco, Colleoni, Alan S, Coates, Richard D, Gelber, Aron, Goldhirsch, Meredith M, Regan

    المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5424a95a06977301869a1612e2b4b1bTest
    https://pubmed.ncbi.nlm.nih.gov/36493334Test


    أضف إلى المفضلة
  6. 6
    Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy

    المؤلفون: Richard D. Gelber, Erika Hitre, Andrea Gombos, Alan S. Coates, Alastair M. Thompson, Sole Investigators, Barbara Ruepp, J Chirgwin, Bettina Müller, Marie-Pascale Graas, Stefan Aebi, Subrina Farah, Joaquín Gavilá, Patrick Neven, K. Ribi, A Courtois, Christian Marth, E Abdi, Per Karlsson, Harold J. Burstein, Katsumasa Kuroi, Seamus O'Reilly, A. Goldhirsch, Thomas Ruhstaller, S. Loibl, Manuela Rabaglio, Marco Colleoni, G. Jerusalem, Giulia Viale, C Kamby, Sherene Loi, Edda Simoncini, Meredith M. Regan

    المصدر: Annals of Oncology. 32:1256-1266

    مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, medicine.medical_treatment, Population, Urology, Breast Neoplasms, Disease-Free Survival, Breast cancer, Nitriles, medicine, Humans, 610 Medicine & health, Adverse effect, education, education.field_of_study, Aromatase Inhibitors, business.industry, Letrozole, Hazard ratio, Estrogens, Hematology, Triazoles, medicine.disease, Confidence interval, Postmenopause, Tamoxifen, Receptors, Estrogen, Oncology, Chemotherapy, Adjuvant, Estrogen, Female, Receptors, Progesterone, business, Adjuvant, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d13705e66773a2ac8689c3630b4e16a4Test
    https://doi.org/10.1016/j.annonc.2021.07.017Test


    أضف إلى المفضلة
  7. 7
    Abstract P5-12-01: SOLE (study of letrozole extension), a phase 3 randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer (BC): Final analysis and sole estrogen substudy (SOLE-EST)

    المؤلفون: Bettina Müller, Per Karlsson, Stefan Aebi, Giuseppe Viale, Andrea Gombos, Edda Simoncini, Meredith M. Regan, Joaquín Gavilá, Christian Marth, Richard D. Gelber, Thomas Ruhstaller, Subrina Farah, Guy Jerusalem, Erika Hitre, Jacquie Chirgwin, Angelo Di Leo, Harold J. Burstein, Barbara Ruepp, Alan S. Coates, Aron Goldhirsch, Sibylle Loibl, Katsumasa Kuroi, Patrick Neven, Alastair M. Thompson, Seamus O'Reilly, Marie-Pascale Graas, Claus Kamby, Manuela Rabaglio, Marco Colleoni

    المصدر: Cancer Research. 80:P5-12

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Randomization, business.industry, medicine.drug_class, Letrozole, Cancer, medicine.disease, law.invention, Breast cancer, Randomized controlled trial, law, Estrogen, Internal medicine, medicine, Clinical endpoint, Adjuvant therapy, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a6e54bad6c0740821d10c521aac674ddTest
    https://doi.org/10.1158/1538-7445.sabcs19-p5-12-01Test


    أضف إلى المفضلة
  8. 8
    Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

    المؤلفون: Barbara Ruepp, Rupert Bartsch, Andrea Gombos, Frances M. Boyle, Giuseppe Viale, Anita Hiltbrunner, Thomas Bachelot, Martine Piccart-Gebhart, Caitlin Mahoney, Debora Fumagalli, Rina Hui, Theodora Goulioti, Fabrice Andre, Marco Colleoni, Carmen Comune, Magdelena Weber, Michelle Jenkins, Stefan Aebi, Stefania Andrighetto, Stamatina Fournarakou, Meredith M. Regan, Colleen King, Angelo Di Leo, Alan S. Coates, Rita Hui, Aron Goldhirsch, Mario Campone, Per Karlsson, Rolf A. Stahel, Vassiliki Karantza, Hui Huang, Laura Biganzoli, Hervé Bonnefoi, Sabrina Ribeli-Hofmann, Roswitha Kammler, Magdalena Sánchez-Hohl, Karolyn Scott, Patrick Schneier, Giuseppe Curigliano, Ingrid Kössler, Sherene Loi, Heather Findlay, Richard D. Gelber, Holly Shaw, Guy Jerusalem, Susan Fischer, Anita Giobbie-Hurder, Daniela Celotto, Manuela Rabaglio-Poretti, Rita Pfister, Michela Frapolli, Monica Greco, Adriana Gasca, Mark J. Smyth, Jaime A. Mejia, Karen N. Price, Heidi Roschitzki, Rudolf Maibach

    المصدر: The Lancet Oncology. 20:371-382

    مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, medicine.medical_specialty, Adolescent, Receptor, ErbB-2, Programmed Cell Death 1 Receptor, Population, Phases of clinical research, Breast Neoplasms, Pembrolizumab, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Trastuzumab, Internal medicine, Clinical endpoint, Humans, Medicine, education, Adverse effect, Aged, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Respiratory infection, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Female, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c82df1b8c95501ce112a4b83da1b9d4Test
    https://doi.org/10.1016/s1470-2045Test(18)30812-x


    أضف إلى المفضلة
  9. 9
    Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial

    المؤلفون: Bent Ejlertsen, Ines Vaz-Luis, Beat Thürlimann, Richard D. Gelber, Bernard F. Cole, Andrew M Wardley, Anita Giobbie-Hurder, Hervé Bonnefoi, Manuela Rabaglio, Marco Colleoni, Aron Goldhirsch, Vernon Harvey, Jose Pablo Leone, Meredith M. Regan, Patrick Neven, István Láng, Angelo Di Leo, Alan S. Coates, Nan Lin

    المصدر: CancerReferences. 127(5)

    مصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Breast Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Interquartile range, Internal medicine, Medicine, Humans, 030212 general & internal medicine, 610 Medicine & health, Aged, Proportional Hazards Models, business.industry, Letrozole, Hazard ratio, Estrogen Receptor alpha, Middle Aged, medicine.disease, Confidence interval, Clinical trial, Tamoxifen, Receptors, Estrogen, 030220 oncology & carcinogenesis, Lymphatic Metastasis, Female, Hormone therapy, Neoplasm Recurrence, Local, business, Receptors, Progesterone, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6207eac2874883ec018e1719b493ea30Test
    https://pubmed.ncbi.nlm.nih.gov/33290610Test


    أضف إلى المفضلة
  10. 10
    Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

    المؤلفون: Monica Castiglione, Vernon Harvey, Anita Giobbie-Hurder, Richard D. Gelber, István Láng, Andrew M Wardley, Barbara Ruepp, Alan S. Coates, Manuela Rabaglio, Marco Colleoni, Beat Thürlimann, Zhuoxin Sun, Hervé Bonnefoi, Patrick Neven, Meredith M. Regan, Bent Ejlertsen, Rudolf Maibach, Aron Goldhirsch

    المصدر: Rabaglio, M, Sun, Z, Maibach, R, Giobbie-Hurder, A, Ejlertsen, B, Harvey, V J, Neven, P, Láng, I, Bonnefoi, H, Wardley, A, Ruepp, B, Castiglione, M, Coates, A S, Gelber, R D, Goldhirsch, A, Colleoni, M, Thürlimann, B & Regan, M M 2021, ' Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence : a report from the BIG 1-98 trial ', Breast Cancer Research and Treatment, vol. 185, no. 3, pp. 697-707 . https://doi.org/10.1007/s10549-020-05981-zTest

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Antineoplastic Agents, Hormonal, medicine.drug_class, Breast Neoplasms, Disease-Free Survival, Cardiovascular events, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Adjuvant endocrine therapy, Internal medicine, Nitriles, Medicine, Humans, Cumulative incidence, Adverse effect, 610 Medicine & health, Aromatase inhibitor, business.industry, Proportional hazards model, Aromatase Inhibitors, Letrozole, Incidence, Hazard ratio, Triazoles, medicine.disease, Postmenopause, Tamoxifen, 030104 developmental biology, Cardiovascular Diseases, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, business, medicine.drug

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fb20f44cce7fd8bf8c7d10f497988aTest
    https://pubmed.ncbi.nlm.nih.gov/33159633Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث